GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 118 filers reported holding GENOMIC HEALTH INC in Q4 2013. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,585,000 | +2.1% | 87,943 | +0.5% | 0.00% | 0.0% |
Q3 2016 | $2,532,000 | +4.3% | 87,540 | -6.6% | 0.00% | 0.0% |
Q2 2016 | $2,427,000 | +8.5% | 93,730 | +3.8% | 0.00% | 0.0% |
Q1 2016 | $2,236,000 | -28.6% | 90,258 | +1.5% | 0.00% | -25.0% |
Q4 2015 | $3,130,000 | +66.4% | 88,934 | +0.1% | 0.00% | +33.3% |
Q3 2015 | $1,881,000 | -23.9% | 88,881 | -0.1% | 0.00% | 0.0% |
Q2 2015 | $2,472,000 | +7.4% | 88,940 | +18.0% | 0.00% | 0.0% |
Q1 2015 | $2,302,000 | -3.1% | 75,353 | +1.4% | 0.00% | 0.0% |
Q4 2014 | $2,375,000 | +42.4% | 74,296 | +26.1% | 0.00% | +50.0% |
Q3 2014 | $1,668,000 | +3.3% | 58,907 | +0.0% | 0.00% | 0.0% |
Q2 2014 | $1,614,000 | +31.8% | 58,895 | +26.6% | 0.00% | 0.0% |
Q1 2014 | $1,225,000 | -9.7% | 46,519 | +0.4% | 0.00% | 0.0% |
Q4 2013 | $1,356,000 | -6.0% | 46,319 | -1.8% | 0.00% | 0.0% |
Q3 2013 | $1,443,000 | +3.2% | 47,183 | +7.0% | 0.00% | 0.0% |
Q2 2013 | $1,398,000 | – | 44,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |